RARA and breast cancer: In this, the top 5 canonical pathways enriched in DEGs include TR/RXR activation (p = 0.0003), breast cancer regulation by Stathmin1 (p = 0.0040), ERK/MAPK signaling (p = 0.0044), PXR/RXR activation (p = 0.0046), and RAR activation (p = 0.0049) (Figure 3).